MCL1 and melanoma: The outcome of treatment with PN, cell death or senescence, might also depend on other molecules crucial for melanoma proliferation and survival such as MCL-1, and therefore melanoma tumors have to be molecularly characterized to select appropriate drugs for combined treatment.